Atıf İçin Kopyala
Bekpinar S., Yenidunya G., Gurdol F., Unlucerci Y., Aycan-Ustyol E., Dinccag N.
CLINICAL BIOCHEMISTRY, cilt.48, sa.18, ss.1264-1267, 2015 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
48
Sayı:
18
-
Basım Tarihi:
2015
-
Doi Numarası:
10.1016/j.clinbiochem.2015.08.001
-
Dergi Adı:
CLINICAL BIOCHEMISTRY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1264-1267
-
Anahtar Kelimeler:
Sphingosine 1-phosphate, Diabetic nephropathy, Apoprotein M, Symmetric dimethylarginine, Asymmetric dimethylarginine, Albuminuria, ENDOTHELIAL BARRIER FUNCTION, ASYMMETRIC DIMETHYLARGININE, APOLIPOPROTEIN M, HDL, ADMA, PROGRESSION, METABOLISM, MECHANISM, MELLITUS, ALBUMIN
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Objectives: Sphingosine 1-phosphate (S1P) is carried in plasma by the HDL particles and albumin. It mediates several protective functions of HDL. Because of its barrier-enhancing effect, it has attracted attention in diseases associated with endothelial dysfunction. We examined the impact of circulating levels of S1P in diabetic nephropathy together with apoprotein M, a S1P-binding protein in HDL. Plasma levels of dimethylarginines were evaluated in this context.